Table 4 Multiple logistic regression analysis of suspected risk factors affecting treatment outcomes
Factor | Unadjusted OR (95% CI) | P | Adjusted OR (95% CI) | P |
|---|---|---|---|---|
Age | 1.20 (0.96–1.49) | 0.11 | 1.31 (0.92–1.88) | 0.14 |
SE refraction of amblyopic eye > 3D | 4.57 (1.82–11.50) |  < 0.01 | 2.75 (0.60–12.48) | 0.19 |
Interocular difference of SE > 3D | 4.34 (1.80–10.45) |  < 0.01 | 0.20 (0.03–1.39) | 0.10 |
Interocular difference of initial BCVA | 27.59 (5.34–142.44) |  < 0.01 | 0.84 (0.04–16.24) | 0.91 |
Interocular difference of BCVA after refractive adaptation | 251.15 (16.68–4974.08) |  < 0.01 | 93.32 (0.53–16,430.64) | 0.09 |
Vertical PEP deviation | 1.11 (1.05–1.18) |  < 0.01 | 1.12 (1.02–1.22) | 0.01 |
Stereoacuity | 21.00 (5.81–75.92) |  < 0.01 | 7.72 (1.50–39.85) | 0.02 |
Interocular suppression | 5.27 (1.75–15.86) |  < 0.01 | 2.86 (0.52–15.66) | 0.23 |